TScan Therapeutics
TCRX
TCRX
27 hedge funds and large institutions have $83.5M invested in TScan Therapeutics in 2021 Q3 according to their latest regulatory filings, with 27 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Holders
27
Holders Change
+27
Holders Change %
–
% of All Funds
0.47%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
%
% of All Funds
0.04%
New
27
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
BlackRock
New York
|
$12.5M |
| 2 |
BBA
2
Baker Bros. Advisors
New York
|
$11.9M |
| 3 |
HA
3
HHLR Advisors
Grand Cayman,
Cayman Islands
|
$10.7M |
| 4 |
RCM
4
RA Capital Management
Boston,
Massachusetts
|
$10.5M |
| 5 |
DIC
5
Deer IX & Co
Larchmont,
New York
|
$9.35M |
Top Sellers
No sellers this quarter
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
26
Royal Bank of Canada
Toronto,
Ontario, Canada
| $8K | 1,000 | +1,000 | New |
|
|
CFGS
27
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|
28
Wells Fargo
San Francisco,
California
| $0 | 41 | +41 | New |
|